Back to discover
Disease

Menstruation Disturbances

Late-stage therapeutic developmentEmerging research
MeSHMenstruation Disturbances
1
Publications
9
Clinical trials
2024
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial expected to report results, the earliest in Q3 2026.
Upcoming Milestones
Clinical Milestones1View
Results expected 1
Activity timeline1

Clinical trials

7 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
9
All trials
1
Active
3
Late-stage
6
Completed
Recently completed

The Treatment of Menstrually-Related Mood Disorders With the Gonadotropin Releasing Hormone (GnRH) Agonist, Depot Leuprolide Acetate (Lupron)

Phase 1 · Completed · National Institute of Mental Health (NIMH)

Investigation of Female Reproductive Hormone Dynamics During Adolescence

Early Phase 1 · Completed · Massachusetts General Hospital

Tamoxifen for the Treatment of Unfavorable Bleeding Patterns in Etonogestrel Contraceptive Implant Users

Phase 4 · Completed · Oregon Health and Science University

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of a Combination of Levonorgestrel and Ethinyl Estradiol in a Continuous Daily Regimen in Subjects With Premenstrual Dysphoric Disorder

Phase 3 · Completed · Wyeth is now a wholly owned subsidiary of Pfizer

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of a Combination of Levonorgestrel and Ethinyl Estradiol in a Continuous Daily Regimen in Subjects With Premenstrual Dysphoric Disorder

Phase 3 · Completed · Wyeth is now a wholly owned subsidiary of Pfizer

Effects of Moderate Aerobic Exercise Combined With Caloric Restriction on Circulating Estrogens and IGF-I in Premenopausal Women

N/A · Completed · Penn State University

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes3
  • Athletic Performance1
  • Menstruation Disturbances1
  • Relative Energy Deficiency in Sport1
Leading journals1
  • Sports medicine (Auckland, N.Z.)1
Leading researchers7
  • Ackerman KE1
  • Hackney AC1
  • Heikura IA1
  • Ihalainen JK1
  • Mikkonen RS1
  • Mjøsund K1
  • Valtonen M1
Affiliations (unnormalised)6
  • Boston Children's Hospital1
  • Canadian Sport Institute-Pacific1
  • Finnish Institute of High Performance Sport KIHU1
  • Massachusetts General Hospital and Harvard Medical School1
  • National Olympic Training Centre Helsinki1
  • Paavo Nurmi Centre and Unit for Health and Physical Activity1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Variations of MENSTRUATION which may be indicative of disease.

Identifiers
MeSHMenstruation Disturbances
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.